Skip to main content
Clinical Trials/NCT02291692
NCT02291692
Completed
Phase 4

Ultrasound Guided Thoracic Paravertebral Block

Cukurova University0 sites40 target enrollmentJune 2013

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
Cukurova University
Enrollment
40
Primary Endpoint
Pain score
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The investigators aimed to evaluate the effect of ultrasound guided thoracic paravertebral block with bupivacaine on both perioperative anesthetic agent consumption and postoperative analgesia in pediatric patients undergoing percutaneous nephrolithotomy for kidney stone.

Detailed Description

This study was performed after approval of Ethics Committee and parents written consent. Between the ages 1-5, planned percutaneous nephrolithotomy due to kidney stones 40 patients were enrolled in this study, and patients were randomly divided into two group. All patients were performed general anaesthesia. The Group I patients was given ultrasound guided thoracic paravertebral block with 0.5 ml/kg bupivacaine %0.5 after giving prone position and the Group II patients was given 15 mg/kg of paracetamol as postoperative analgesia. In the period of postoperative, if the FLACC \> 4; it was planned to dose 1 mg/kg of tramadol. Patients' hemodynamic parameters, oxygen saturation, sevoflurane concentration were recorded 10, 15, 30 and 60 minutes intraoperatively. Patients' hemodynamic parameters, oxygen saturation, pain scores (FLACC), satisfaction of parents, the number of patients who additional analgesic requirements and side effects (nausea,vomiting, hypotension, bradycardia, respiration problems etc) were recorded in the postoperative period. Primary outcome measures was pain scores using FLACC scale.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
December 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zehra

Zehra Hatipoglu

Cukurova University

Eligibility Criteria

Inclusion Criteria

  • ASA physical status I-II
  • Between the ages of 1-5 years
  • Forty children

Exclusion Criteria

  • Refusals by parents
  • Children with spine deformities
  • Cutaneous infection
  • Bleeding diathesis
  • Allergy to drugs used
  • ASA physical status III-IV

Outcomes

Primary Outcomes

Pain score

Time Frame: 12 hours

Similar Trials